Search results for

More films could be deemed to be still under copyright following two rulings from Tokyo's District Court

Peter Ollier, Hong Kong

Pfizer has won a key victory in the Chinese courts over the patent for sildenafil citrate, the active ingredient in its impotence drug

Insurers have traditionally steered clear of the risky business of protecting intangible assets. But not any more, says Garry Booth

Managing IP, in association with Oblon Spivak McClelland Maier & Neustadt, gathered together representatives of the different views on patent reform in the US to discuss the major changes planned, and the impact they will have on IP owners and applicants

Law firms and patent and trade mark agencies are reporting record levels of demand from IP clients. Managing IP published a list of the largest practices across the globe in its September 2007 issue. The tables for the US and Canada are reprinted here

Managing IP spoke to the UK's new minister for IP, Lord Triesman, to discuss the role of the IP Office, upholding the public domain and how to make the UK fake-free

The 2007 edition of the Americas IP Focus is published amid important changes in IP practice. Nowhere is this more true than in the Americas. In the US, Congress is debating fundamental changes to patent law, arising from concerns over the scope of protection and abuse of the vagaries of the patent system, while the Supreme Court has, in the past year, delivered four decisions of fundamental importance to IP owners. Meanwhile, new means of monetizing patents are being tested and the USPTO has introduced controversial reforms to address its backlog and delays in both the patent and trade mark fields.

The European Commission recently published figures for 2006 relating to seizures by national Customs authorities of goods infringing IP rights on their entry into the EU. These reveal a considerable increase in the number of counterfeit and pirated articles being seized generally, Customs seizing more than 250 million articles in 2006 compared with 75 million in 2005; but in particular highlight a rapid growth in the trade of counterfeit medicines.

On August 6 2007, the Intellectual Property Office of Taiwan implemented an overhaul of the standards related to the examination of biotech inventions.